KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories Signs Landmark Collaborative Agreement with Government Agency in Southeast Asia to Advance Spider Silk Production

Kraig Biocraft Laboratories Signs Landmark Collaborative Agreement with Government Agency in Southeast Asia to Advance Spider Silk Production

ANN ARBOR, Mich., July 28, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the formal signing of a multi-year agreement with a government agency in Southeast Asia to support the scale-up of its recombinant spider silk production.

This agreement is the result of many years of groundwork by Kraig Labs and marks a significant step in the Company's ongoing efforts to commercialize next-generation biomaterials. Under the terms of the agreement, Kraig Labs will gain access to government-supported rearing facilities, technical personnel, and infrastructure critical to accelerating production and expanding operational capacity.

"This milestone reflects many years of work by our senior management and on-the-ground team," said COO of Kraig Labs, Jon Rice. "With the support of this agreement, we are now positioned to move more quickly and efficiently toward large-scale commercialization."

Kraig Labs expects to take possession of the new facility and initiate operations in early August.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit .

For details about other recent Kraig Labs advancements, please watch the Company's investor conference at or on the Company's YouTube Channel .

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to   

* For a description of our historical leadership in this technology, please follow this link

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495



EN
28/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlig...

24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production March issue of National Geographic explores how engineered silkworms are spinning one of nature’s most powerful materials at scale DENVER, Feb. 24, 2026 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the undisputed global leader in the development and commercialization o...

 PRESS RELEASE

Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Medi...

Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger DENVER, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Wall Street opens to a convergence of science, scale, and strategic consolidation. From spider silk making mainstream headlines to multibillion-dollar oncology deals and accelerating immunotherapy revenues, today’s tape reflects capital flowing toward platforms with validation. Kraig Biocraft Laboratories Featured on National Geographic Cover Shares of Kraig Biocraft Laboratories (OTCQB:KBLB) could see elevated interest after the company’s recombinant spider silk ...

 PRESS RELEASE

Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the ...

Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue ANN ARBOR, Mich., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that its groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine. National Geographic highlights Kraig Labs’ advancements in producing spider silk fibers using genetically enhanced silkworms. The ...

 PRESS RELEASE

24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spid...

24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough One Million Transgenic Silkworms Being Deployed as Production Targets 10 Metric Tons per Month DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the undisputed global leader in the development and commercialization of spider silk, is entering what may prove to be the defining phase of its multi-decade development ...

 PRESS RELEASE

Kraig Biocraft Laboratories Activates First Wave of 2026 Production Pr...

Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program ANN ARBOR, Mich., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that its 2026 production plan has officially moved from strategy to execution. The Company has now moved bio-material to incubation, getting a jumpstart on its March production plan and formally initiating its multi-ton spider silk scale-up initiative. This milestone follows Kraig’s recently announced 2026 produ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch